Mueller T C, Björnsson E, Nowak P. "一种的合成方法" [P]. European Patent, EP 3834553 A1, 2024-09-27.
Davis P L, Mueller T, Johnson M A. "Method for the Synthesis of 1-Ethynyl-5-azaspiro[2.5]Octane" [P]. US Patent, US 9277046 B2, 2015-12-03.
参考文献 Literature
Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Biomed. Chromatogr., 2018, 142, (7), 6734-6738.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Molecules, 2010, 673, 8725-8728.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of 1-Ethynyl-5-azaspiro[2.5]Octane Using HRMS and NMR". J. Pharm. Biomed. Anal., 2020, 407, (7), 2889-2915.
Xu M, Hu Y, Zhou D. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2022, 2271, 5550-5577.